4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine

C66H63N17O3 — CID 157314962

IUPAC4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine
SMILESCc1ccc(-n2c(-c3cnc(N4CCOCC4)cc3C)nc3ccncc32)cc1.c1cc2nc(-c3cnc(N4CCOCC4)nc3)n(-c3ccc(C4CC4)cc3)c2cn1.c1ccc(-n2c(-c3cnc(N4CCOCC4)nc3)nc3ccncc32)cc1
InChIInChI=1S/C23H22N6O.C23H23N5O.C20H18N6O/c1-2-16(1)17-3-5-19(6-4-17)29-21-15-24-8-7-20(21)27-22(29)18-13-25-23(26-14-18)28-9-11-30-12-10-28;1-16-3-5-18(6-4-16)28-21-15-24-8-7-20(21)26-23(28)19-14-25-22(13-17(19)2)27-9-11-29-12-10-27;1-2-4-16(5-3-1)26-18-14-21-7-6-17(18)24-19(26)15-12-22-20(23-13-15)25-8-10-27-11-9-25/h3-8,13-16H,1-2,9-12H2;3-8,13-15H,9-12H2,1-2H3;1-7,12-14H,8-11H2
InChIKeyBDMFTVURGAPLQB-UHFFFAOYSA-N
MW1142.35 g/mol
LogP10.24
Rot. Bonds10

About 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine

4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine (PubChem CID 157314962) has the molecular formula C66H63N17O3 and a molecular weight of 1142.35 g/mol. Its IUPAC name is 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine.

Molecular Properties

Compound Name4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine
PubChem CID157314962
Molecular FormulaC66H63N17O3
Molecular Weight1142.35 g/mol
Exact Mass1141.53
IUPAC Name4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine
SMILESCc1ccc(-n2c(-c3cnc(N4CCOCC4)cc3C)nc3ccncc32)cc1.c1cc2nc(-c3cnc(N4CCOCC4)nc3)n(-c3ccc(C4CC4)cc3)c2cn1.c1ccc(-n2c(-c3cnc(N4CCOCC4)nc3)nc3ccncc32)cc1
InChIInChI=1S/C23H22N6O.C23H23N5O.C20H18N6O/c1-2-16(1)17-3-5-19(6-4-17)29-21-15-24-8-7-20(21)27-22(29)18-13-25-23(26-14-18)28-9-11-30-12-10-28;1-16-3-5-18(6-4-16)28-21-15-24-8-7-20(21)26-23(28)19-14-25-22(13-17(19)2)27-9-11-29-12-10-27;1-2-4-16(5-3-1)26-18-14-21-7-6-17(18)24-19(26)15-12-22-20(23-13-15)25-8-10-27-11-9-25/h3-8,13-16H,1-2,9-12H2;3-8,13-15H,9-12H2,1-2H3;1-7,12-14H,8-11H2
InChIKeyBDMFTVURGAPLQB-UHFFFAOYSA-N
XLogP10.24
TPSA193.99 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds10
Heavy Atoms86
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001142.35
LogP ≤ 510.24
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Analyze 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-[[4-(2-Methyl-5-pyridin-4-ylimidazo[4,5-b]pyridin-3-yl)phenyl]methyl]morpholine
CID 146315950
2-[[4-[4,4-Bis(4-fluorophenyl)butyl]piperazin-1-yl]methyl]-3-(2-ethoxyethyl)imidazo[4,5-b]pyridine
CID 9828521
4-[6-[4-[2-(3,4-Difluorophenyl)ethyl]piperazin-1-yl]-8-methyl-3,5,8,12-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-13-yl]morpholine
CID 11454703
4-[5-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]pyrimidin-2-yl]morpholine
CID 168283226
[1-[3-[3-[4-(1-Aminocyclobutyl)phenyl]-2-(2-amino-3-pyridinyl)imidazo[4,5-b]pyridin-5-yl]phenyl]piperidin-4-yl]-morpholin-4-ylmethanone
CID 71138594
US9725449, Example 270
CID 122686547
4-[8-Methyl-9-[(4-pyridin-3-ylphenyl)methyl]purin-6-yl]morpholine
CID 137632065
4-[8-Methyl-9-[(4-pyridin-4-ylphenyl)methyl]purin-6-yl]morpholine
CID 137644374
4-[8-Methyl-9-[[4-(2-methyl-4-pyridinyl)phenyl]methyl]purin-6-yl]morpholine
CID 137651999
4-[8-Methyl-9-[(4-pyrimidin-5-ylphenyl)methyl]purin-6-yl]morpholine
CID 137656637
1-methyl-6-(4-morpholin-4-ylphenyl)-N-phenylimidazo[4,5-c]pyridin-2-amine
CID 117769842
2-cyclopropyl-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-1,8-naphthyridine
CID 50939210

Frequently Asked Questions

What is the IUPAC name of 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine?
The IUPAC name of 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine (CID 157314962) is 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine.
What is the SMILES notation for 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine?
The canonical SMILES for 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine is Cc1ccc(-n2c(-c3cnc(N4CCOCC4)cc3C)nc3ccncc32)cc1.c1cc2nc(-c3cnc(N4CCOCC4)nc3)n(-c3ccc(C4CC4)cc3)c2cn1.c1ccc(-n2c(-c3cnc(N4CCOCC4)nc3)nc3ccncc32)cc1.
What is the InChIKey of 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine?
The InChIKey is BDMFTVURGAPLQB-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H22N6O.C23H23N5O.C20H18N6O/c1-2-16(1)17-3-5-19(6-4-17)29-21-15-24-8-7-20(21)27-22(29)18-13-25-23(26-14-18)28-9-11-30-12-10-28;1-16-3-5-18(6-4-16)28-21-15-24-8-7-20(21)26-23(28)19-14-25-22(13-17(19)2)27-9-11-29-12-10-27;1-2-4-16(5-3-1)26-18-14-21-7-6-17(18)24-19(26)15-12-22-20(23-13-15)25-8-10-27-11-9-25/h3-8,13-16H,1-2,9-12H2;3-8,13-15H,9-12H2,1-2H3;1-7,12-14H,8-11H2.
What are the key properties of 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine?
4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine has a molecular weight of 1142.35 g/mol, XLogP of 10.24, 10 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-[3-(4-cyclopropylphenyl)imidazo[4,5-c]pyridin-2-yl]pyrimidin-2-yl]morpholine;4-[4-methyl-5-[3-(4-methylphenyl)imidazo[4,5-c]pyridin-2-yl]-2-pyridinyl]morpholine;4-[5-(3-phenylimidazo[4,5-c]pyridin-2-yl)pyrimidin-2-yl]morpholine is sourced from PubChem (CID 157314962), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).